Updated 1 week ago
Lateral Flow Assay OEM Services for Custom Diagnostic Tests
trustlabofficial
Unbranded lateral flow test cassettes on a laboratory bench during OEM product review.
Lateral flow assay OEM (original equipment manufacturing) is a contract manufacturing arrangement in which a specialist manufacturer produces lateral flow rapid tests for another company, which then sells them under its own brand. The buyer avoids the cost and complexity of building its own production line while still gaining access to a finished diagnostic product, manufacturing quality systems, and technical documentation.
This guide explains what lateral flow assay OEM and ODM services include, how the development process works, and how to evaluate a manufacturing partner for a custom or private-label diagnostic test.
What Does a Lateral Flow Assay OEM or ODM Service Include?
An OEM/ODM partner for lateral flow assays can provide far more than production. Depending on the project, the manufacturer may be responsible for:
- Assay design and feasibility studies
- Reagent selection and optimization
- Prototype and sample production
- Verification and validation work
- Scale-up to commercial manufacturing
- Quality control and lot-release testing
- Packaging and labeling
- Regulatory documentation and design history files
- Storage and batch traceability
The exact scope depends on whether the project is an OEM, ODM, or private-label arrangement. Those terms are often used interchangeably in the diagnostic industry, but they describe different levels of responsibility.
OEM vs ODM vs Private Label — What's the Difference?
| Service Model | What It Usually Means | Who Owns the Design Work |
|---|---|---|
| OEM | A manufacturer produces a test to the buyer's agreed specification. The buyer may supply the design, or the design may be jointly adapted from the manufacturer's existing technology. | Typically shared or buyer-directed |
| ODM | The manufacturer designs and develops the product, then offers it to the buyer under the buyer's brand. The buyer specifies requirements rather than providing a finished product design. | Manufacturer-led |
| Private label | The buyer takes an existing manufactured product and sells it under its own brand, usually with customized packaging and labeling. | Manufacturer-owned |
In real-world diagnostic projects, the boundaries can blur. A buyer may call an arrangement OEM even when the manufacturer owns most of the assay design. That is why it is better to define responsibilities than to rely on a single label.
Before starting a project, clarify:
- Who is responsible for assay design and reagent selection?
- Who owns the product and documentation if the relationship ends?
- Which regulatory submissions are the manufacturer expected to support?
- What changes are allowed after initial production?
These questions affect cost, timeline, regulatory strategy, and your long-term control over the product.
The Lateral Flow Assay Development Process — From Concept to Production
A lateral flow assay OEM project usually follows the same broad stages, regardless of manufacturer. Understanding those stages helps you plan resources, review technical progress, and set realistic expectations with your partner.
| Stage | What Happens | Typical Deliverable |
|---|---|---|
| Concept and specification | Define the target analyte, sample type, intended use, and performance goals. | Product specification |
| Feasibility and reagent selection | Assess antibody pairs, labels, membrane types, buffers, and sample pads. | Feasibility report |
| Prototype and optimization | Build trial strips and adjust reagent concentrations and component drying to improve signal consistency. | Working prototype |
| Verification | Confirm the product meets the agreed design specifications across repeated runs. | Verification data |
| Validation | Establish that the test performs as intended for the stated use, including clinical or analytical studies where required. | Validation report |
| Design transfer | Move the approved design into production-scale manufacturing. | Manufacturing documents and batch records |
| Scale-up and production | Produce commercial batches under controlled manufacturing conditions. | Commercial product |
| Quality control and release | Test each batch for function, appearance, and consistency before release. | Lot release documentation |
The label used for each stage varies between companies. Some manufacturers compress feasibility and prototype work into a single phase; others separate analytical validation from clinical validation. What matters is that the process is documented, traceable, and agreed before production begins.
Verification vs Validation — What Each Means for Your Product
Verification and validation are often bundled together, but they answer different questions:
- Verification asks: Did we build the product according to its design specifications? It is an internal check that the test performs as the design documentation says it should.
- Validation asks: Does the product work for its intended use in real-world conditions? It examines whether the test is suitable for the target population, specimen type, and setting in which it will be used.
Both generate evidence. That evidence is usually captured in the product's design history file (DHF) and is the foundation for regulatory submissions in many markets.
If an OEM partner cannot clearly explain what verification and validation data they will provide, treat that as a risk factor. Regulatory bodies expect the technical file to contain more than final test results; they look for evidence that the product was developed in a controlled and documented way.
How to Qualify a Lateral Flow Assemby OEM Partner
Qualifying a lateral flow assay OEM partner is not just about price and turnaround time. The right partner should demonstrate capability in four areas: quality systems, facility standards, technical documentation, and regulatory support.
Quality System Certification
The most important certification to look for is ISO 13485, the international quality management system standard for medical devices, including in vitro diagnostics. An ISO 13485 certificate means the manufacturer's processes for design, production, storage, and distribution have been audited against the standard.
Keep the scope precise: ISO 13485 certifies the quality management system, not every product or product claim. It is not the same as CE marking, FDA clearance, or a clinical performance statement. Ask to see the certificate as well as any product-level regulatory documents that apply to your target market.
Another relevant document is ISO/DTS 24883, a technical specification that provides guidance specifically for lateral flow immunoassay rapid diagnostic tests. It is not a replacement for ISO 13485, but it shows the manufacturer is familiar with lateral-flow-specific design and production considerations.
Facility Standards
Lateral flow tests are produced in controlled environments because humidity, temperature, and contamination can change reagent behavior. Many commercial manufacturers operate cleanroom or GMP-controlled production areas to reduce that risk.
When evaluating a facility, ask:
- Which production stages are performed in a controlled environment?
- What environmental monitoring is done during production?
- How is contamination risk managed during strip assembly and cassette housing?
Cleanroom language should not be confused with sterility. Most lateral flow tests are not supplied sterile. The important point is that manufacturing conditions are controlled well enough to produce consistent tests from lot to lot.
Technical Documentation
A capable OEM partner should be able to provide, or help you generate, the following types of documentation:
- Product and component specifications
- Manufacturing batch records
- Verification and validation protocols and reports
- Stability data
- Quality control release criteria
- Labeling and instructions for use (IFU)
The depth of documentation you need depends on your regulatory pathway. Even if you enter a lower-risk market, complete documentation helps you compare offers and makes future regulatory expansion easier.
Regulatory Support
Ask each partner which regulatory submissions they have supported. Some manufacturers are experienced with CE marking under the EU IVDR, others with FDA submissions, WHO prequalification, or country-level registrations.
A manufacturer cannot normally register the device on your behalf in every market. In most arrangements, the buyer remains the regulatory owner and the manufacturer supplies the technical evidence. What you want is a partner who understands what evidence your target market will require and can produce it in a usable format.
Existing Product Quality
One practical way to assess a potential manufacturer is to review its existing rapid tests. Product pages, instruction leaflets, and packaging can tell you a lot about the manufacturer's quality culture and the test formats they already produce.
Trustlab's product range includes several lateral flow tests across different disease areas:
Looking at existing test formats is a useful starting point when you discuss which product design, specimen type, and packaging options are relevant to your project.
Questions to Ask a Lateral Flow Assay OEM Partner
Use the following questions as a starting point in early discussions. The answers will tell you more about the manufacturer's process than a brochure ever will.
- Can you share your ISO 13485 certificate and state the scope of activities it covers?
- Which steps of the lateral flow manufacturing process do you handle in-house?
- Which materials, components, and reagents do you source from suppliers?
- What is your process for handling a project that starts with an existing test design?
- What is your process for a project that requires new assay development?
- How are verification and validation handled, and who is responsible for the studies?
- What clinical or analytical data do you provide for a new product?
- Can you support regulatory submissions in my target markets?
- What quality control tests are performed on each production batch?
- How do you demonstrate whatever consistency across batches?
- What packaging and labeling options do you offer for private-label buyers?
- What volume ranges can you support from pilot batches to commercial production?
Regulatory and Documentation Considerations for OEM/Private-Label Tests
The regulatory path for a lateral flow assay depends on the product's intended use, the specimen types it analyzes, and the country or region where it will be sold. A test intended for professional laboratory use is treated differently from a test intended for self-testing, and infectious-disease tests may have additional requirements.
OEM buyers should be clear about their target market early because it affects the evidence package the manufacturer must provide.
| Target Market | Typical Regulatory Context |
|---|---|
| European Union | CE marking under the In Vitro Diagnostic Regulation (IVDR) for most in vitro diagnostic tests |
| United States | FDA framework for in vitro diagnostics, with the level of regulatory control depending on device classification |
| Global procurement | WHO prequalification of in vitro diagnostics, often required for good organization procurement programs |
| Local markets | Country-specific registration, licensing, or import approval processes |
A manufacturer's quality system documentation supports these submissions, but it does not remove the buyer's responsibility for the product.
A few distinctions are worth carrying through every conversation:
- ISO 13485 certification is a quality system certificate. It is not a CE certificate and not an FDA clearance.
- CE marking is product-level conformity assessment for EU market access.
- Product registration is different from the manufacturer's certificate.
- Verification and validation data must match the exact product design and intended use.
If a manufacturer cannot explain which regulatory requirement applies to their product format, get more detail before signing an agreement. A well-managed OEM relationship should make regulatory planning easier, not harder.
How to Start an OEM Engagement with a Lateral Flow Assay Manufacturer
Starting an OEM project is straightforward if you prepare the right information before your first conversation.
Most manufacturers will ask about the target analyte, sample type, intended use, target markets, and expected production volumes. The more clearly you define those requirements, the faster the partner can assess feasibility and provide a realistic project plan.
A practical first step looks like this:
- Write a short product brief covering the analyte, sample type, readout format, and target user.
- Note the regulatory region where you plan to sell the test.
- Estimate the volume you need for launch and for the first 12 months.
- Contact the manufacturer with your brief and ask which service model applies to your project.
- Expect a questionnaire or specification sheet in return.
- Review feasibility, development milestones, and documentation support.
You do not need to be an assay developer to start the conversation. You do need to know enough about your market and intended use to explain what your product must do. The manufacturer's job is to translate that into a manufacturable test.
If you are evaluating a lateral flow OEM partner, start the conversation with a clear product brief. Contact Trustlab to discuss your project, ask for the relevant specifications, and find out what development and documentation support is available for your test format.
